참고문헌
- Albert, R., French, J., Maronpot, R., Spalding, J. and Tennant, R. (1996): Mechanism of skin tumorigenesis by contact sensitizers: The effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4dinitro-1-fluorobenzene in the skin of the Tg.AC (v-Ha-ras) mouse. Environmental Health Perspectives, 104, 1062-1068 https://doi.org/10.2307/3433118
- Berg, R.J.W., De Vries, A., Van Steeg, H. and De Gruijl, F.R. (1997): Relative susceptibilities of XPA knockout mice, and their heterozygous, and wild-type littermates to UVB-induced skin cancer. Cancer Res., 57, 581-584
- Bucher, J.R. (1998): Update on National Toxicology Program (NTP) assays with genetically altered or 'Transgenic' mice. Environmental Health Perspectives., 106, 619-622. http://ntp.niehs.nih.gov/ https://doi.org/10.2307/3434087
- DeGeorge, J. (2001): Regulatory perspective on application of the transgenic alternatives in pharmaceutical development. Presented at the annual meeting of the society of toxicologic pathologists, Orlendo, FL
- de Vries, A., Van Oostrum, C.T.M., Hofhuis, F.M.A., Dortant, P.M., Berg, R.J.W., De Gruijl, F.R., Wester, P.W., Van Kreijl, C.F., Capel, P.J.A., Van Steeg, H. and Verbeek, S.J. (1995): Increased susceptability to ultraviolet-B and carcinogenesis of mice lacking the DNA excision repair gene Xpa. Nature, 337, 169-173 https://doi.org/10.1038/337169a0
- de Vries, A., Van Oostrum, C.T.M., Hofhuis, F.M.A., Dortant, P.M., Beems, R.B., Berg, R.J.W., Van Kreijl, C.F., Capel, P.J.A. and Van Steeg, H. (1997): Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in Xpa deficient mice. Molec. Carcinogen., 19, 46-53. https://doi.org/10.1002/(SICI)1098-2744(199705)19:1<46::AID-MC7>3.0.CO;2-L
- de Vries, A., van Steeg, A. and Opperhuizen. (2004). RIVM report 340700001/2004, Transgenic mice as alternatives in carcinogenicity testing: current status, Netherlands
- Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A.J., Butel, J.S. and Bradley, A. (1992): Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221 https://doi.org/10.1038/356215a0
- Eastin, W.C., Haseman, J.K., Mahler, J.F. and Bucher J.R. (1998): The National Toxicology program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol., 26, 461-473 https://doi.org/10.1177/019262339802600401
- Floyd, E., Mann, P., Long, G. and Ochoa, R. (2002): The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists. Toxicol. Pathol., 30, 147-156 https://doi.org/10.1080/01926230252824860
- French, J., Haseman, J., Donehower, L., Hajian, G., LeGrand, E., Long, G., Ochoa, R., Sagartz, J., Mixon, L., Soper, K. and Storer, R. (2000): The P53+/- heterozygous knockout mouse model for short-term carcinogenicity testing. ILSI/HESI workshop on evaluation of alternative methods for carcinogenicity testing, Leesburg, VA
- Hansen, L.A. and Tennant, R.W. (1994): Follicular origin of epidermal papillomas in v-Ha-ras transgenic TG.AC mouse skin. Proc. Natl. Acad Sci USA, 91, 7822-7826 https://doi.org/10.1073/pnas.91.16.7822
- Hansen, L.A., Trempus, C.S., Mahler, J.F. and Tennant, R.W. (1996): Association of tumor development with increased cellular proliferation and transgene overexpression but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice. Carcinogenesis, 17, 1825-1833 https://doi.org/10.1093/carcin/17.9.1825
- Hansen, L.A., Spalding, J.W., French, J.E. and Tennant, R.W. (1994): A transgenic mouse model (TG.AC) for skin carcinogenesis: Inducible transgene expression as a second critical event. In McClain, R.M., Slaga, T.J., LeBoeuf, R. and Pitot, H. (eds.), Growth Factors and Tumor Promotion: Implications for Risk Assessment, Vol. 391. Wile-Liss, Barton Creek, Texas, pp. 223-235
- Harvey, M., McArthur, M.J., Montgomery, C.A.J., Butel, J.S., Bradley, A. and Donehower, L.A. (1993a): Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet., 5, 225-229 https://doi.org/10.1038/ng1193-225
- Harvey, M., McArthur, M.J., Montgomery, C.A.J., Bradley, A. and Donehower, L.A. (1993b): Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J., 7, 938-943 https://doi.org/10.1096/fasebj.7.10.8344491
- http://hesi.ilsi.org, ILSI HESI ACT:Alternatives to Carcinogenicity Testing
- http://ntp.niehs.nih.gov/, Bucher, J R. Update on National Toxicology Program (NTP) assays with genetically altered or 'Transgenic' mice
- http://www.item.fraunhofer.de/reni. ACT: Alternatives to Carcinogenicity Testing
- ICH (1997): Guidance on safety testing for carcinogenicity of pharmaceuticals. Fed. Reg., 63, 8983-8986
- ICH (1998): Expert working group on safety, Guidance for industry S1B testing for carcinogenicity of pharmaceuticals
- Jacobson-Krarn, D., Sistare F.D. and Jacobs, A.C. (2004): Use of transgenic mice in carcinogenicity hazard assessment. Toxicol. Pathol., 32(Suppl. 1), 49-52 https://doi.org/10.1080/01926230490424761
- Leder, A., Kuo, A., Cardiff, R.D., Sinn, E. and Leder, P. (1990): v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA, 87, 9178-9182 https://doi.org/10.1073/pnas.87.23.9178
- Linda, B.A., Woutersen, R.A., Bruijntjes, J.P., Benthem, J.V., van den Berg, J.A.H., Monbaliu, J., Thoolen, B.J.J.M., Beems, R.B. and van Kreijl, C.F. (2004): Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and d-mannitol. Toxicol. Pathol., 32, 192-201 https://doi.org/10.1080/01926230490274344
- MacDonald, J., French, J.E., Gerson, R.J., Goodman, G.J., Inoue, T., Jacobs, A., Kasper, P., Keller, D., Lavin, A., Long, G., McCullough, B., Sistare, F.D., Storer, R. and van der laan, J.W. (2004): The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. Toxicol. Sci., 77, 188-194 https://doi.org/10.1093/toxsci/kfh037
- Maronpot, M.M., Fox, T., Malarkey, D.E. and Goldworthy, T. (1995): Mutations in the ras proto-oncogene:Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology, 101, 125-156 https://doi.org/10.1016/0300-483X(95)03112-S
- Mastorides, S. and Maronpot, R.R. (2002): Carcinogenesis. In: Handbook of toxicologic pathology. 2nd ed. Ed Haschek, W.M., Rousseaux, C.G., Wallig, M.A., pp. 83-122
- Morton, D., Alden, C.L., Roth, A.J. and Usui, T., (2002): The Tg rasH2 mouse in cancer hazard identification. Toxicol. Pathol., 30, 139-146 https://doi.org/10.1080/01926230252824851
- Nylander-French, L. and French, J. (1998): Tripropylene glycol diacrylate, but not ethyl acrylate, induces skin tumors in a twenty week short term tumorigenesis study in Tg.AC (v-Ha-ras) mice. Toxico. Pathol., 26, 476-483 https://doi.org/10.1177/019262339802600403
- Ochoa R. (2002): Pathology issues in the design of toxicology studies. In: Handbook of toxicologic pathology. 2nd ed. Ed Haschek, W.M., Rousseaux, C.G., Wallig, M.A., pp. 307-326
- Pritchard, J.B., French, J.E., Davis, B.J. and Haseman, J.K. (2003): The role of transgenic mouse models in carcinogen identification. Environ. Health. Prospect., 111, 1-11
-
Recio, L., Boley, S., Everitt, J., James, R.A., Janszen, D., Healy, L., Roberts, K., Walker, D., Pluta, L. and French, J.E. (2000): Cancer bioassay and genotoxicity of inhaled benzene in
$p53^{+/-} $ and C57B16 mice. Toxicologist, 54, 222 - Robinson, D.E. and MacDonald, J.S. (2001): Background and frame work for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. Toxicol. Pathol., 29(Suppl), 13-19 https://doi.org/10.1080/019262301753178438
-
Sanders, J.M., Burka, L.T., Chanas, B. and Matthews, H.B. (2001): Comparative xenobiotic metabolism between Tg.AC and
$p53^{+/-} $ genetically altered mice and their respective wild types. Toxicol. Sci., 61, 54-61 https://doi.org/10.1093/toxsci/61.1.54 -
Storer, R.D., French, J.E., Haseman, J., Hajian, G., LeGrand, E.K., Long, G.G., Mixon, L.A., Ochoa, R., Sagartz, J.E. and Soperm K.A. (2001):
$p53^{+/-} $ hemizygous knockout mouse: overview of the available data. Toxicol. Pathol., 29(Suppl), 30-50 https://doi.org/10.1080/019262301753178465 - Spalding, J.W., Momma, J., Elwell, M.R. and Tennant, R.W. (1993): Chemical induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Carcinogenesis, 14, 1335-1341 https://doi.org/10.1093/carcin/14.7.1335
- Suemizu, H., Ohnishi, Y., Maruyama, C., Tomisawa, M., Muguruma, K., Hioki, K., Usui, T., Kimura, M., Tamaoki, N. and Nomura, T. (2002): Molecular biological studies in the rasH2 transgenic mouse. In: Workshop on the evaluation of alternative methods for carcinogenicity testing. International Life Sciences Institute, Washington, DC
-
Takaoka, M., Sehata, S., Maejima, T., Imai, T., Torii, M., Satoh, H., Toyosawa, K., Tanakamaru, Z.-Y., Adachi, T., Hisada, S., Ueda, M., Ogasawara, H., Matsumoto, M., Kobayashi, K., Mutai, M. and Usui, T. (2003): Interlaboratory comparison of short-term carcinogenicity studies using
$CB6F_1 $ -rasH2 transgenic mice. Toxieol. Pathol., 31, 191-199 https://doi.org/10.1080/01926230390183670 - Tennant, R.W., French, J.E. and Spalding, J.W. (1995): Identification of chemical carcinogens and assessing potential risk in short term bioassays using transgenic mouse models. Environ. Health. Perspeet., 103, 942-950 https://doi.org/10.2307/3432740
- Tennant, R.W., Spalding, J.W. and French, J.E. (1996): Evaluation of transgenic mouse bioassays for identifying carcinogens and non-carcinogens. Mut. Res., 395, 119-127 https://doi.org/10.1016/S0165-1110(96)90016-0
- Van Oostrum, C.T.M., Boeve, M., Van den Berg, J., de Vries, A., Dolle, M.E.T., Beems, R.B., Van Kreijl, C.F., Vijg, J. and Van Steeg, H. (1999): The effect of heterozygous loss of p53 on benzo a pyrene-induced mutations and tumours in DNA repair-deficient Xpa mice. Environ. Mol. Mutagen., 34, 124-30 https://doi.org/10.1002/(SICI)1098-2280(1999)34:2/3<124::AID-EM11>3.0.CO;2-F
- Watanabe, K. (2004): Research and development of the Tg rasH2 mice model. Presented at the seminar at Huntingdon Life Sciences, Huntingdon, UK